| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 04/08/2004 | CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/07/2004 | EP1405859A1 Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof and intermediate therefor |
| 04/07/2004 | EP1404693A2 C12 modified erythromycin macrolides and ketolides having antibacterial activity |
| 04/07/2004 | EP1404692A1 Antimitotic eleuthesides |
| 04/07/2004 | CN1486712A Extractive of Chinese medicinal material rabdosia as antitumor medicine and its prepn process |
| 04/06/2004 | US6716820 Bactericides |
| 04/06/2004 | CA2089563C Oligonucleotide modulation of cell adhesion |
| 04/06/2004 | CA2087286C Thioether conjugates |
| 04/01/2004 | WO2004026889A1 Antibiotic derivatives of erythromycin |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063646 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 03/31/2004 | EP1032581B1 Chemical synthesis of 6-o-alkyl erythromycin a |
| 03/31/2004 | EP1032580B1 Process for n-desmethylating erythromycins and derivatives thereof |
| 03/31/2004 | CN1485325A Soybean extract with health-care function , its preparing process and use |
| 03/31/2004 | CN1485324A Method of membrane separation technique for producing seabuckthorn flavone |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
| 03/30/2004 | US6713615 Process for producing erythromycin derivative |
| 03/30/2004 | US6713455 6-O-carbamate-11,12-lacto-ketolide antimicrobials |
| 03/25/2004 | WO2004024744A2 Production of glycosylated macrolides in e. coli |
| 03/25/2004 | WO2004009608A3 Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof |
| 03/25/2004 | WO2003094842A3 Conjugates comprising central nervous system active drug |
| 03/25/2004 | US20040058879 Processes for preparing clarithromycin polymorphs and novel polymorph IV |
| 03/24/2004 | EP1400529A1 Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 03/24/2004 | EP1400528A1 An improved process for the preparation of azithromycin monohydrate |
| 03/24/2004 | EP1399458A1 An arylation method for the functionalization of o-allyl erythromycin derivatives |
| 03/24/2004 | CN1483734A Novel process for extracting puerarin from pueraria mirifica |
| 03/24/2004 | CN1142923C 12,13-modified epothilone derivatives |
| 03/23/2004 | US6710189 Genetically engineered polyketide synthase for use in the generation of preferential antibiotics |
| 03/23/2004 | US6710034 5-O-mycaminosyltylonide derivatives |
| 03/18/2004 | WO2004022572A1 Compounds that interact with kinases |
| 03/18/2004 | WO2004011477A3 6,11-4-carbon bridged ketolides |
| 03/18/2004 | US20040053862 Macrolide solvates |
| 03/18/2004 | US20040053861 Drugs comprising macromolecules, prodrugs and carriers mixtures administered for prophylaxis gramnegative bacterial infections; antibiotics |
| 03/18/2004 | US20040053860 Flavonoid derivatives for the treatment of eczema |
| 03/18/2004 | US20040053859 Preventive or therapeutic agent for cancer containing cyanidin compound as active ingredient |
| 03/18/2004 | US20040053858 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 03/18/2004 | US20040053854 Process for preparation of 4,5-Epoxymorphinan-6-oxyglucuronides |
| 03/17/2004 | EP1397105A1 Methods for inhibiting angiogenesis |
| 03/17/2004 | CN1482908A Phase transfer catalyzed glycosidation of an indolocarbazole |
| 03/17/2004 | CN1142173C Method for enriching iridoid glycoside compound from picrorhiza root |
| 03/16/2004 | US6706865 Process for preparing flavonoids |
| 03/16/2004 | US6706692 Staphylococci, streptococci, pneumococci |
| 03/16/2004 | US6706292 Recovery of isoflavones from soy molasses |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019879A2 Motilide compounds |
| 03/11/2004 | WO2003105766A3 Rsk inhibitors and therapeutic uses thereof |
| 03/11/2004 | WO2003090679A3 11-deoxy azalide antibacterials |
| 03/11/2004 | US20040048813 A solution of a spinosyn including spinosad, spinosyn A, and/or spinosyn D |
| 03/10/2004 | EP1216256B1 Macrolide antibiotics and treatment of pasteurellosis |
| 03/10/2004 | EP1100762B1 Erythromycin derivatives with antibiotic activity |
| 03/10/2004 | EP0957911B1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 03/10/2004 | CN1480461A Metching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 03/10/2004 | CN1141313C Method for preparing erythromycin derivs. |
| 03/10/2004 | CN1141312C 15-membered lactams ketolides with antibacterial activity |
| 03/10/2004 | CN1141311C Method of extracting erythromycin from fermentation liquid by phase transition extraction |
| 03/09/2004 | US6703372 Macrolides |
| 03/04/2004 | WO2004018491A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 03/04/2004 | WO2003022844A3 Synthesis of epothilones intermediates thereto and analogues thereof |
| 03/04/2004 | WO2002068442A8 Salts of avermectins substituted in the 4'-position and having pesticidal properties |
| 03/04/2004 | US20040044067 Anticholesterol agents; dietetics; plant extract |
| 03/04/2004 | US20040043945 Crystal forms of azithromycin |
| 03/04/2004 | US20040043944 Form of azithromycin selected from the group consisting of forms D, E, substantially pure F, G, J, M substantially in the absence of azithromycin dihydrate, N, O, P, Q, and R; NMR spectrun analysis; bactericides; antiprotozoa agents; infections of mammals, birtds, and fish; drug resistance |
| 03/04/2004 | DE10240923A1 Flavonoid-Derivate zur Ekzem-Behandlung Flavonoid derivatives for eczema treatment |
| 03/03/2004 | EP1393733A1 Flavonoid-derivate for the treatment of eczema |
| 03/03/2004 | EP1392701A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
| 03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 03/03/2004 | EP1283821B1 A cost effective method for selective methylation of erythromycin a derivatives |
| 03/03/2004 | EP1131331B1 13-membered azalides and their use as antibiotic agents |
| 03/03/2004 | EP1121134B1 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
| 03/03/2004 | CN1478787A 3-glyeosyl flavone or its derivative and its preparation method and use |
| 03/03/2004 | CN1140535C Halo derivatives of 9-deoxo-9a-aza-9a-homery theromycin A. |
| 02/26/2004 | WO2004016634A1 Novel 11,12-Substituted Lactone Ketolide Derivatives Having Antibacterial Activity |
| 02/26/2004 | WO2004016633A1 Salt of morphine-6-glucuronide |
| 02/26/2004 | WO2004016632A2 Lincomycin derivatives possessing antibacterial activity |
| 02/26/2004 | WO2004000864A3 11-c-substituted ketolides |
| 02/26/2004 | WO2002068438A3 9a-n-[n'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a and of 5-0-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide a |
| 02/26/2004 | US20040039066 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 02/26/2004 | US20040038927 Methods of decreasing or preventing pain using spicamycin derivaties |
| 02/26/2004 | US20040038915 Novel 11,12-substituted lactone ketolide derivatives having antibacterial activity |
| 02/26/2004 | CA2493799A1 Lincomycin derivatives possessing antibacterial activity |
| 02/25/2004 | EP1390507A2 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 02/25/2004 | EP1390377A1 Crystal forms of azithromycin |
| 02/25/2004 | EP1025114B1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
| 02/25/2004 | EP0965344B1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
| 02/24/2004 | US6696485 Cocoa extracts; antitumor, anticancer activity; oxidation resistance; dna topoisomerase ii enzyme inhibition |
| 02/19/2004 | WO2004014932A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 02/19/2004 | WO2004014405A1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 02/19/2004 | WO2004014295A2 Tiacumicin production |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | WO2003020236A3 The utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection |
| 02/19/2004 | US20040034205 Chiral (1pyrrolino) fullerene derivatives |
| 02/19/2004 | US20040033970 For treatment of bacterial infections |
| 02/19/2004 | US20040033969 Such as penicillin G coupled to 2'deoxyazithromycin; drug delivery |
| 02/19/2004 | US20040033962 Antibody directed enzyme prodrug therapy |
| 02/19/2004 | CA2494742A1 Tiacumicin production |
| 02/18/2004 | EP1389621A1 N-substituted pyrazolyl-o-glycoside derivatives and remedial agent for diabetes containing the same |
| 02/18/2004 | EP1389216A2 Avermectins substituted in the 4"-position having pesticidal properties |
| 02/18/2004 | EP1014968B1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR |
| 02/18/2004 | EP0876388B1 Tricyclic erythromycin derivatives |